Insider Shareholders with Direct Ownership of 2seventy Bio, Inc. (TSVT)
This section provides a comprehensive overview of the insiders with direct ownership of 2seventy Bio, Inc. (TSVT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
2seventy bio, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction | 
|---|---|---|---|---|---|
| 1,356,794 | 1,438,479 | 1,233,606 $6.17 Million | 18 |                   
            Jan 06, 2025
              Reduced 0.07%
           | |
| 
                  
                    Philip D Gregory
                  
                   Chief Scientific Officer | 350,804 | 47,627 | 310,280 $1.55 Million | 13 |                   
            Jan 08, 2024
              Added 20.38%
           | 
| 
                  
                    Nicola Heffron
                  
                   Chief Operating Officer | 99,187 | 11,101 | 89,182 $445,910 | 10 |                   
            Feb 07, 2023
              Reduced 0.07%
           | 
| 
                  
                    Casdin Capital, Llc
                  
                   Director | 6,025 | 22,625 | 22,625 $113,125 | 2 |                   
            Jun 10, 2024
              Added 21.03%
           | 
| 18,403 | 0 | 21,053 $105,265 | 3 |                   
            Jun 13, 2023
              Added 28.52%
           | |
| 19,050 | 0 | 19,050 $95,250 | 3 |                   
            Jun 13, 2023
              Added 30.6%
           | |
| 
                  
                    William R. Sellers
                  
                   Director | 2,221 | 0 | 3,202 $16,010 | 1 |                   
            Nov 11, 2021
              Added 38.47%
           | 
| 
                  
                    William D Baird Iii
                  
                   President and CEO | 1,219,391 | 1,222,066 | 0 $0 | 22 |                   
            May 13, 2025
              Reduced 100.0%
           | 
| 
                  
                    Kynam Capital Management, Lp
                  
                   > 10% Shareholder | 86,414 | 0 | 0 $0 | 1 | 
              N/A
             | 
| 31,144 | 31,560 | 0 $0 | 5 |                   
            May 13, 2025
              Reduced 100.0%
           | |
| 27,652 | 27,652 | 0 $0 | 5 |                   
            May 13, 2025
              Reduced 100.0%
           | |
| 22,625 | 22,625 | 0 $0 | 3 |                   
            May 13, 2025
              Reduced 100.0%
           | |
| 32,850 | 32,850 | 0 $0 | 4 |                   
            May 13, 2025
              Reduced 100.0%
           | |
| 27,652 | 27,652 | 0 $0 | 6 |                   
            May 13, 2025
              Reduced 100.0%
           | |
| 
                  
                    Bluebird Bio, Inc.
                  
                   > 10% Shareholder | 23,368,988 | 23,369,088 | 0 $0 | 2 |                   
            Nov 04, 2021
              Reduced 100.0%
           | 
| 
                  
                    Kynam Global Healthcare Master Fund, Lp
                  
                   > 10% Shareholder | 86,414 | 5,142,111 | 0 $0 | 2 | 
              N/A
             | 
| 
                  
                    Victoria Eatwell
                  
                   Chief Financial Officer | 396,364 | 450,511 | 0 $0 | 11 |                   
            May 13, 2025
              Reduced 100.0%
           | 
| 
                  
                    Jessica Snow
                  
                   Chief Operating Officer | 245,938 | 278,352 | 0 $0 | 14 |                   
            May 13, 2025
              Reduced 100.0%
           |